Welcome to the e-CCO Library!

P336: Can Mesenchymal Stem Cell (MSC) apoptosis be used as a biomarker for treatment success in perianal fistulising Crohn’s Disease (pCD)? Findings from a prospective pilot study
Year: 2022
Source: ECCO'22
Authors: Iqbal, N.(1,2);Constable, L.(3,4);Tozer, P.(1,2);Lung, P.(1);Hart, A.(1,4);Powell, N.(4);
Created: Friday, 11 February 2022, 3:52 PM
P336: Endoscopic scores as predictors of treatment failure in Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ferreira, A.I.(1)*;Lima Capela, T.(1);Xavier, S.(1);Arieira, C.(1);Cúrdia Gonçalves, T.(1);Dias de Castro, F.(1);Moreira, M.J.(1);Cotter, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P336: French prospective, longitudinal observational study of the therapeutic management of mild to moderate ulcerative colitis (Optimum study): follow-up at 3 years
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Nahon*1, G. Bonnaud2, F. Bahbah3

Created: Friday, 22 February 2019, 9:49 AM
P336: Is endoscopy necessary to measure disease activity in ulcerative colitis: A systematic narrative review
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Restellini1,2*, C.-Y. Chao1,3, O. Kherad4, M. Martel5, A.N. Barkun1, E. Seidman1, G. Wild1, A. Bitton1, W. Afif1, T. Bessissow1, P.L. Lakatos1,6

Created: Thursday, 21 February 2019, 9:14 AM
P336: Safety of anti-TNF treatment in older IBD patients: a systematic review and meta-analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Waars S.1, Dekkers N.1, van der Meulen A.1, Stijnen T.2, Maljaars J.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P337 Usefulness of drug-level monitoring in therapeutic guidance in patients with ulcerative colitis on anti-TNF-α maintenance therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E.H. Oh1, Y. A-Ran2, K. Ye-Jee3, K. Jeongseok1, N. Namseok1, P. Sang Hyoung4, Y. Dong-Hoon1, B. Jeong-Sik1, M. Seung-Jae1, Y. Suk-Kyun4, Y. Byong Duk4

Created: Thursday, 30 January 2020, 10:12 AM
P337: Anti-TNFalpha therapy is associated with rapid reduction of circulating monocyte numbers and blunted monocyte pro-inflammatory response in patients with Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Slevin*1, C. Dennedy2, A. Ribeiro1, R. Ceredig1, M. Griffin1, L. Egan2

Created: Friday, 22 February 2019, 9:49 AM
P337: Developing Preliminary MRI-based Classifier for Perianal Fistulizing Crohn's Disease by Using Deep Convolutional Neural Networks
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Zhang, H.(1)*;Li, L.(2);Deng, K.(2);Li , W.(3);Ren, D.(1);
Created: Friday, 14 July 2023, 11:05 AM
P337: Early infliximab clearance predicts remission in children with Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Chung, A.(1);Carroll, M.(1);Almeida, P.(1);Petrova, A.(1);Mould, D.(2);Wine, E.(1);Huynh, H.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P337: Efficacy of intravenous cyclosporine in fulminant steroid-refractory ulcerative colitis with massive bleeding: a retrospective, observational study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ogashiwa T., Nishio M., Otake H., Inoue E., Kimura H., Kunisaki R.

Created: Wednesday, 20 February 2019, 10:36 AM
P337: Low seroprevalence of celiac disease in a large screening study in unselected Swiss IBD cohort patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Biedermann on behalf of the Swiss IBD Cohort Study Group1*, F. Wüstholz2, N. Fournier3, T. Greuter2, P. Schreiner2, B. Misselwitz2, J. Zeitz4, M. Scharl2, P. Frei5, E. Safroneeva6, A. Schoepfer7, M. Kaelin8, G. Rogler2, S.R. Vavricka9

Created: Thursday, 21 February 2019, 9:14 AM
P337: Switching from originator infliximab to CT-P13: single-centre experience from the UK
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. P. Bhandare*1, B. Crooks1, G. B. Nigam1, J. K. Limdi1,2

Created: Friday, 22 February 2019, 9:41 AM
P337: Therapeutic drug monitoring: standardization of Promonitor Quick IFX and Promonitor Quick ADL point of care tests with WHO International Standards for the quantification of infliximab and adalimumab in whole blood and serum
Year: 2022
Source: ECCO'22
Authors: Ametzazurra, A.(1);Pascual, J.(1);Del Rio, L.(1);Urigoitia, A.(1);Nagore, D.(1);Ruiz-Argüello, M.B.(1);
Created: Friday, 11 February 2022, 3:52 PM
P338 The effectiveness of a standardised biologic care pathway in the management and treatment of inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Willett1, C.G. Heisler1, N. Nazer1, B. Currie1, K. Phalen-Kelly1, M. Stewart2, J. Jones2

Created: Thursday, 30 January 2020, 10:12 AM
P338: Early proactive drug monitoring strategy of infliximab as monotherapy for inflammatory bowel disease in paediatric patients is associated with good sustained clinical remission
Year: 2022
Source: ECCO'22
Authors: Girard, C.(1);Achkar, S.(2);Sassine, S.(2);Chapuy, L.(3);Jantchou, P.(1);Deslandres, C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P338: effectiveness and safety of biological therapies in elderly inflammatory bowel diseases patients results from a multi center study of Geteccu
Year: 2021
Source: ECCO'21 Virtual
Authors: Suarez Ferrer, C.J.(1);Mesonero , F.(2);Caballol, B.(3);Saiz Chumillas, R.(4);Bastón-Rey, I.(5);Rubin de Celix, C.(6);Melcarne, L.(7);Caballero Mateos, A.(8);Calafat, M.(9);Alonso Galan, H.(10);Vega Villaamil, P.(11);Castro Senosiain, B.(12);Rodriguez Diaz, C.Y.(13);Plaza Santos, R.(14);Marques Cami, M.(15);Rodriguez Grau, M.C.(16);Ramirez, F.(17);Lopez-García, A.(18);Gomez Pastrana, B.(19);Gonzalez Partida, I.(20);Botella Mateu, B.(21);Cuevas del Campo, L.(22);Gonzalez Peña, E.(23);Iyo, E.(24);Elosua Gonzalez, A.(25);Sainz, E.(26);Hernandez, L.(27);Perez Galindo, P.(28);Rueda Garcia, J.L.(29);Martin-Arranz, M.D.(29);Lopez Sanroman, A.(30);Fernandez-Clotet, A.(3);Sicilia, B.(4);Calviño Suárez, C.(5);Mañosa Ciria, M.(9);Barreiro-De Acosta, M.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P338: Long-term complications in patients with fistulising Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Vuyyuru*1, S. Kedia1, P. Sahu1, S. Bopanna1, S. Jain1, G. Makharia1, V. Ahuja1

Created: Friday, 22 February 2019, 9:41 AM
P338: Outcome of hospitalised patients with inflammatory bowel disease complicated by Clostridium difficile infection: Results from a tertiary referral centre
Year: 2018
Source: ECCO '18 Vienna
Authors:

O. Stoica1*, C. Stanciu2, A.-M. Singeap3, I. Girleanu3, S. Chiriac1, C. Muzica1, A. Trifan3

Created: Thursday, 21 February 2019, 9:14 AM
P338: Rate and predictors of mucosal healing in patients with ulcerative colitis treated with thiopurines: results of a multicentric cohort study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Prieux-Klotz*1, S. Nahon2, A. Amiot3, L. Sinayoko4, C. Galéano-Cassaz5, S. Chaussade1, P. Lahmek6, V. Abitbol1

Created: Friday, 22 February 2019, 9:49 AM
P338: Transmural healing is not associated with less disability than complete endoscopic mucosal healing: a prospective study in a patient with Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yzet, C.(1);Brazier, F.(2);Hautefeuille, V.(2);Grados, L.(2);Decrombecque, C.(2);Diouf, M.(3);Fumery, M.(2)*;
Created: Friday, 14 July 2023, 11:05 AM